Active, not recruiting
A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
NCT06614855
- Conditions
- Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +13 more
- Locations
-
- The University of Alabama at Birmingham Hospital Birmingham, Alabama, United States